Funded Grants

Grants awarded in the current fiscal year and carried over from prior fiscal years.

PI Name Sort descending	PI Organization	Title	Grant Number	Initiative	Program Official
Knoerl, Robert James	University Of Michigan At Ann Arbor United States	Determining the Feasibility of Virtual Tailored, Music-Based Relaxation for Anxiety Among Adolescent and Young Adult Cancer Survivors.	5R34CA286712-02		Goli Samimi, Ph.D., M.P.H.
Kober, Kord Michael	University Of California, San Francisco United States	An Investigation of the Molecular Mechanisms for and Prediction of the Severity of Cancer Chemotherapy-Related Fatigue Using a Multi-staged Integrated Omics Approach	5R37CA233774-07		Brandy Heckman-Stoddard, Ph.D., M.P.H.
Kolb, Noah Allan	University Of Vermont & St Agric College United States	Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy	5R01CA247517-05		Brennan Streck, Ph.D., RN, M.P.H.
Kong, Mei	University Of California-Irvine United States	Using dietary glutamine supplementation for melanoma prevention and targeted therapy	5R01CA244360-05	PA-20-185 (Parent R01 Clinical Trial Not Allowed)	Gabriela Riscuta, M.D., CNS
Kooperberg, Charles L	Fred Hutchinson Cancer Center United States	Statistics and Data Management Center (SDMC) for the NCI Cancer Screening Research Network (CSRN)	5UG1CA287013-02		Elyse LeeVan, M.D., M.P.H.
Kresty, Laura A	University Of Michigan At Ann Arbor United States	Developing Natural Products to Target IL-8 Signaling and Intercept Progression of Barrett’s Esophagus to Esophageal Adenocarcinoma	1UG3CA299397-01		Altaf Mohammed, Ph.D.
Krist, Alexander H	Virginia Commonwealth University United States	Virginia Cancer Screening Research Network Access Hub (Virginia CSRN Hub)	3UG1CA287017-02S1		Elyse LeeVan, M.D., M.P.H.
Kroetz, Deanna L	Ohio State University United States	Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity	5R01CA261068-06		Rachel Altshuler, Ph.D.
Kuhn, Peter	University Of Southern California United States	Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple Myeloma	4U01CA285013-03		Nicholas Hodges, Ph.D.
Kumar, Nagi B.	H. Lee Moffitt Cancer Ctr & Res Inst United States	Phase II Clinical trial of GTC in Men on Active Surveillance	5R01CA235032-06		Howard L. Parnes, M.D.